Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 11 studies | 85% ± 17% | |
type I pneumocyte | 8 studies | 32% ± 23% | |
club cell | 5 studies | 43% ± 29% | |
T cell | 3 studies | 50% ± 32% | |
endothelial cell of lymphatic vessel | 3 studies | 45% ± 36% | |
fibroblast | 3 studies | 43% ± 36% | |
ciliated cell | 3 studies | 44% ± 34% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 7 studies | 33% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 219784.55 | 577 / 578 | 65% | 1970.10 | 745 / 1155 |
thymus | 69% | 50.08 | 451 / 653 | 10% | 73.34 | 60 / 605 |
pancreas | 74% | 32.98 | 244 / 328 | 0% | 0 | 0 / 178 |
heart | 56% | 44.81 | 478 / 861 | 0% | 0 | 0 / 0 |
prostate | 55% | 22.55 | 134 / 245 | 0% | 0 | 0 / 502 |
esophagus | 52% | 23.81 | 751 / 1445 | 1% | 8.77 | 1 / 183 |
adrenal gland | 52% | 38.06 | 133 / 258 | 0% | 0 | 0 / 230 |
intestine | 51% | 28.32 | 495 / 966 | 0% | 0.45 | 1 / 527 |
peripheral blood | 50% | 62.33 | 461 / 929 | 0% | 0 | 0 / 0 |
adipose | 50% | 37.87 | 597 / 1204 | 0% | 0 | 0 / 0 |
muscle | 50% | 38.06 | 398 / 803 | 0% | 0 | 0 / 0 |
stomach | 49% | 19.48 | 177 / 359 | 0% | 0 | 0 / 286 |
brain | 48% | 27.50 | 1277 / 2642 | 0% | 0 | 0 / 705 |
breast | 48% | 22.21 | 220 / 459 | 0% | 0 | 0 / 1118 |
blood vessel | 46% | 47.43 | 612 / 1335 | 0% | 0 | 0 / 0 |
ovary | 46% | 388.79 | 82 / 180 | 0% | 0 | 0 / 430 |
liver | 45% | 39.71 | 102 / 226 | 0% | 0 | 0 / 406 |
spleen | 45% | 16.80 | 108 / 241 | 0% | 0 | 0 / 0 |
skin | 44% | 49.69 | 787 / 1809 | 1% | 8.31 | 6 / 472 |
kidney | 44% | 17.65 | 39 / 89 | 0% | 0 | 0 / 901 |
uterus | 42% | 15.51 | 72 / 170 | 0% | 0 | 0 / 459 |
bladder | 5% | 0.95 | 1 / 21 | 6% | 175.92 | 30 / 504 |
tonsil | 0% | 0 | 0 / 0 | 2% | 1.95 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008228 | Biological process | opsonization |
GO_0006869 | Biological process | lipid transport |
GO_0007585 | Biological process | respiratory gaseous exchange by respiratory system |
GO_0045334 | Cellular component | clathrin-coated endocytic vesicle |
GO_0005615 | Cellular component | extracellular space |
GO_0005581 | Cellular component | collagen trimer |
GO_0005576 | Cellular component | extracellular region |
GO_0042599 | Cellular component | lamellar body |
GO_0005771 | Cellular component | multivesicular body |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005319 | Molecular function | lipid transporter activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SFTPA1 |
Protein name | Surfactant protein A1 Surfactant protein A1 variant AB'D' 6A (Surfactant protein A1 variant ACD' 6A) Pulmonary surfactant-associated protein A1 (PSP-A) (PSPA) (SP-A) (SP-A1) (35 kDa pulmonary surfactant-associated protein) (Alveolar proteinosis protein) (Collectin-4) |
Synonyms | SFTP1 SFTPA1B COLEC4 SFTPA PSAP |
Description | FUNCTION: In presence of calcium ions, it binds to surfactant phospholipids and contributes to lower the surface tension at the air-liquid interface in the alveoli of the mammalian lung and is essential for normal respiration. Enhances the expression of MYO18A/SP-R210 on alveolar macrophages (By similarity). .; FUNCTION: (Microbial infection) Recognition of M.tuberculosis by dendritic cells may occur partially via this molecule . Can recognize, bind, and opsonize pathogens to enhance their elimination by alveolar macrophages . .; FUNCTION: (Microbial infection) Binds M.pneumoniae CARDS toxin, serves as one receptor for this pathogen . When SFTPA1 is down-regulated by siRNA, less toxin binds to human cells and less vacuolization (a symptom of M.pneumoniae infection) is seen . . |
Accessions | ENST00000429958.5 ENST00000428376.6 [Q8IWL2-1] A0A0C4DG36 K4N2H0 ENST00000419470.6 [Q8IWL2-2] ENST00000398636.8 [Q8IWL2-1] Q8IWL2 |